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Purpose: We evaluated threshold saccadic vector optokinetic perimetry (SVOP) and
compared results to standard automated perimetry (SAP).
Methods: A cross-sectional study was done including 162 subjects (103 with
glaucoma and 59 healthy subjects) recruited at a university hospital. All subjects
underwent SAP and threshold SVOP. SVOP uses an eye tracker to monitor eye
movement responses to stimuli and determines if stimuli have been perceived based
on the vector of the gaze response. The test pattern used was equivalent to SAP 24-2
and stimuli were presented at Goldmann III. Average and pointwise sensitivity values
obtained from both tests were compared using Pearson’s correlation coefficient. Two
versions of SVOP were evaluated.
Results: A total of 124 tests were performed with SAP and SVOP version 2. There was
excellent agreement between mean threshold values obtained using SVOP and SAP (r
¼ 0.95, P , 0.001). Excluding the blind spot, correlation between SVOP and SAP
individual test point sensitivity ranged from 0.61 to 0.90, with 48 of 54 (89%) test
points . 0.70. Overall SVOP showed good repeatability with a Pearson correlation of
0.88. The repeatability on a point-by-point basis ranged from 0.66 to 0.98, with 45 of
54 points (83%) . 0.80. Repeatability of SAP was 0.87, ranging from 0.69 to 0.96, with
47 of 54 (87%) points . 0.80.
Conclusion: Eye-tracking perimetry is repeatable and compares well with the current
gold standard of SAP. The technique has advantages over conventional perimetry and
could be useful for evaluating glaucomatous visual field loss, particularly in patients
who may struggle with conventional perimetry.
Translational Relevance: Suprathreshold SVOP already is in the field. To our
knowledge, this is the first report of threshold SVOP and provides a benchmark for
future iterations.
Introduction
The use of a static white stimulus on a white
background (white-on-white) has become the accept-
ed standard for investigation of visual function in
patients with glaucoma. White-on-white automated
suprathreshold tests often are used for screening
purposes,1 with threshold tests (standard automated
perimetry, SAP) used to aid glaucoma diagnosis and
quantify disease progression.2 Evaluating differential
light sensitivity using threshold testing is an essential
part of glaucoma management; however, full thresh-
old testing is time-consuming, which can have an
adverse effect on reliability. Although newer testing
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strategies, such as the Swedish Interactive Threshold
Algorithm (SITA),3,4 have improved efficiency, many
patients still find SAP difficult.5,6 The requirement to
maintain fixation on a central target, and then signal
perception of a peripheral stimulus, without altering
fixation, can be challenging. In addition, patients are
required to maintain a fixed head position, which may
be problematic. All of these factors can lead to longer
test times and contribute to test–retest variability and
low test reliability.7,8
Saccadic vector optokinetic perimetry (SVOP) is a
technique originally developed to enable suprathresh-
old visual field assessment in children unable to
perform conventional forms of perimetry.9 SVOP uses
eye tracking to assess the visual field by automated
real-time assessment of natural eye movement re-
sponses to stimuli, and has no postural constraints.9,10
Different iterations of the technique have now been
evaluated in children and adults.11,12
We have developed a version of SVOP for
threshold testing. The purpose of this study was to
introduce threshold SVOP and compare SVOP
threshold values to threshold values obtained from
SAP in patients with glaucoma and normal subjects.
A second part to this study is continued in a
companion paper, which compares visual field
patterns obtained by threshold SVOP and SAP, and
evaluates patients’ perceptions of threshold SVOP.
Materials and Methods
Subjects
This cross-sectional study included 103 patients
with glaucoma (age range, 42–91 years; mean age,
70.6 6 8.79 years) and 59 healthy subjects (age range,
50–81 years; mean age, 65.7 6 5.8 years). Patients
with glaucoma were recruited from a nonconsecutive
series of patients attending the glaucoma clinic at the
Princess Alexandra Eye Pavilion, Edinburgh. Healthy
subjects were required to have no previous history of
glaucoma or visual field defect and no neurological
conditions that might affect the visual field. All
subjects provided written informed consent. The
study adhered to the tenets of the Declaration of
Helsinki and was approved by the South-East Scot-
land Research Ethics Committee, NHS Lothian.
All patients attending the glaucoma clinic had
undergone best-corrected visual acuity assessment,
slit-lamp biomicroscopy, intraocular pressure mea-
surement, pachymetry, gonioscopy, and dilated fun-
duscopy. Glaucoma was diagnosed by a glaucoma
specialist, based on the presence of typical glaucoma-
tous changes in optic disc morphology and the
presence of a glaucomatous visual field defect on
SAP, using the Humphrey visual field analyzer (HFA;
Carl Zeiss Meditec, Dublin, CA) SITA Fast 24-2 test.
Patients with strabismus or a history of eye movement
disorders were excluded. All patients had a best
corrected visual acuity of better than 0.3 logMAR. In
the healthy group, eyes with a visual acuity worse
than 0.15 logMAR were excluded.
Test Methods
Each subject underwent SAP (24-2 SITA fast) and
threshold SVOP on both eyes, with the order of
testing randomized. A smaller cohort of subjects
underwent repeat testing in one eye to evaluate
repeatability. For glaucoma patients, repeat testing
was performed on the eye with the more advanced
SAP visual field loss. For healthy subjects, one eye
was selected randomly for repeat testing. Testing was
performed during a single session on the same day
and breaks offered between tests should they be
required. The SVOP and SAP tests used are described
in more detail in the following sections.
SVOP Test
The suprathreshold version of SVOP has been
previously described.9,10 Briefly, the SVOP device
consists of a personal computer, two display screens
(one for the patient and another for the examiner),
and an eye tracker. The eye tracker assesses patient
eye gaze responses to visual field stimuli presented on
the display screen and a software algorithm deter-
mines if the stimuli have been perceived based on the
direction and amplitude of a subject’s eye gaze
responses rather than a patient response button. The
only task required of the patient is to refixate on a
peripheral stimulus, if they have seen it, which then
becomes the fixation target for the next peripheral test
point. A peripheral stimulus will be presented only if
the system determines that the patient is fixating
correctly on the fixation target. The eye tracker also
provides ‘‘real time’’ data on eye location allowing
screen coordinates of visual field stimuli to be
calculated based on the position of the patient,
meaning that there is no requirement for a chin rest.
In other words, the size and position of the stimuli can
be adjusted automatically and continually to com-
pensate for changes in the patient’s position during
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testing. Figure 1 shows the SVOP instrumentation in
use.
Threshold SVOP uses the same underlying princi-
ples as suprathreshold SVOP, with the exception that
the fixation target remains in place until a test
stimulus is seen and an appropriate eye gaze is made.
In the suprathreshold test, the fixation target disap-
pears when a peripheral stimulus is shown so as to
incite an eye movement reaction. In a threshold test
where many stimuli will not be seen, this approach
would lead to lengthy test durations because refix-
ation time would be required for every presented
stimulus.
The eye tracker used for threshold SVOP was an
IS-1 model (Tobii Technology, Stockholm, Sweden).
The patient display screen was a 24 00 ColorEdge
CG243W LCD display (Eizo Corporation, Hakusan,
Japan) controlled by a FirePro 2270 graphics card
(Advanced Micro Devices, Sunnyvale, CA) providing
native 10-bit color depth support. The display was
calibrated to generate accurate representation of the
varying stimulus luminance levels required for thresh-
old testing. Briefly, the screen calibration technique
uses an accurate Look-Up Table (LUT) pairing the
grey-levels of each pixel to the corresponding required
luminance levels. This enabled the accurate reproduc-
tion of the background and stimulus luminance levels
required for threshold testing.13 This method of
calibration was performed once at the beginning of
the study. A second, simpler screen calibration using
an x-rite i1 Display Pro Colourimeter (x-rite Inc.,
Grand Rapids, MI) was used twice during the study
to maintain the display color consistency.
The test pattern used was equivalent to the SAP
24-2 test pattern. Peripheral stimuli were presented at
size Goldmann III for 200 ms each on a background
of 10 cd/m2. Stimuli luminance levels replicated the
luminance values corresponding to 14-40 dB on SAP.
The SVOP threshold sensitivity values were matched
in luminance to those of the SAP to allow direct
comparison. Thresholds were obtained using a 4-2
bracketing strategy and began by testing four ‘‘seed’’
locations (one in each quadrant), which then were
used to set the starting stimulus luminance levels for
neighboring locations, which in turn were used to
calculate the remaining starting luminance levels.
The room lights were off for SAP and SVOP
testing. Participants were seated in front of the patient
screen with their eyes aligned with the center of the
screen at a testing distance of approximately 55 cm,
measured using an eye tracking–based on-screen tool.
Monocular testing was made possible using custom
made test spectacles allowing transferable, full aper-
ture prescription lenses (55 mm diameter) if required,
while also occluding the nontest eye with an infrared
bandpass filter which enabled the eye tracker to detect
the position of the occluded eye. A calibration
sequence, in which the subject was required to follow
a stimulus to nine different screen locations, was
performed before each test to produce accurate eye
gaze data during testing. Before testing commenced, a
20-second demonstration of the test was provided for
all subjects. During testing the patient was instructed
to follow their natural reaction to fixate towards any
peripheral stimulus perceived.
Modifications to SVOP during the Study
Throughout the study, the testing clinicians
(AMcT and LC) liaised with the research engineers
(IM, AP, and HB) to suggest improvements. When
sufficient improvements were developed, version 1
(v1) of the SVOP software was replaced with version 2
(v2). Key changes between software v1 and v2 were:
(1) an indicator for correct patient height and position
(before and throughout the test); (2) an improved
interactive demonstration test; (3) an increased time
period for determining fixation and new fixation
target with central pulsating crosshairs to improve
fixation; (4) ensuring that starting luminance levels
(calculated from ‘‘seed’’ location threshold levels in
each quadrant) and subsequent neighboring threshold
levels were never below 18 dB; this ensured that
threshold point results would never be determined
from a single stimulus decision; and (5) two bug fixes
(one relating to incorrect screen stimuli positions
calculated under rare circumstances, and a second
relating to incorrect calculation of the starting
luminance level for one field point location).
Figure 1. The threshold SVOP instrument showing the patient
screen, eye tracker position, and examiner screen.
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SAP Test
SAP was performed using a HFA 750i (Carl Zeiss
Meditec). The SITA FAST algorithm was used with
the 24-2 test pattern. The eye being tested was aligned
to the central fixation point with the aid of the HFA
on-screen camera. Monocular testing was performed
using an eye patch and, if required, a near prescrip-
tion was provided using full aperture trial lenses
placed in the HFA lens holder. During testing,
participants were instructed to fixate on the light in
the center of the perimetry bowl throughout the test
and to respond to peripheral stimuli by pressing a
patient response button. Individuals who were unfa-
miliar with visual field testing were shown a short
demonstration of the test.
Data Analysis
SVOP tests excluded from analysis were those that
were incomplete. SAP tests excluded from analysis
were those with a false-positive response rate exceed-
ing 15% (deemed as potentially unreliable as recom-
mended by manufacturer guidelines14), and those
identified as having eyelid or lens rim artefact. The
number of excluded tests is reported.
For group comparison tests, normality assump-
tion was assessed by inspection of histograms and
using Shapiro-Wilk tests. For comparison of two
groups, Student’s t-tests were used for normally
distributed variables and the Wilcoxon rank-sum test
for continuous nonnormal variables. For compari-
son of more than two groups, 1-way analysis of
variance (ANOVA) was used. All tests were 2-sided
and a P value less than 0.05 was considered
statistically significant. Statistical analyses were
performed with SPSS version 21 (SPSS Inc., Chica-
go, IL, USA).
SVOP and SAP tests (excluding repeat tests) were
compared by correlating the average sensitivity for
each test to produce a Pearson’s correlation coeffi-
cient (r) for each SVOP software version (v1 and v2).
This analysis was repeated for each of the 54 visual
field test locations. Due to the limitations of the
current SVOP LCD screen, it was not possible to
generate stimuli with brightness greater than 136.69
cd/m2 (corresponding to 14 dB on SAP). Therefore,
visual field sensitivity on SAP tests lower than 14 dB
were truncated to 14 dB for comparison. To assess the
repeatability of SVOP (v1 and v2) and SAP tests,
Pearson correlations were calculated for each pair of
repeat test point measurements on the same eye (54
points per test).
Results
Subjects
A total of 162 subjects took part in the study,
including 103 patients with glaucoma (50 female, 53
male) and 59 healthy subjects (40 female, 19 male). Of
those with glaucoma, 90 had open angle and 13
primary angle closure glaucoma. Healthy subjects
were younger than those with glaucoma (65.7 6 5.8
vs. 70.6 6 8.79 years, respectively; P , 0.001).
Table 1 shows the number of subjects enrolled to
perform SVOP testing with v1 or v2. It also shows
the number of SVOP and SAP tests performed
Table 1. Number of Subjects and Tests (SVOP v1, v2, and SAP) Performed (Excluding Repeat Tests), the
Number (and Reason) of Excluded Tests and the Resultant Comparison Test Pairs Used for Analysis after
Exclusions
SVOP Version
Used during
Visit
Subject
Type N
Number of SVOP Tests
(Left and Right Eyes)
Number of SAP Tests
(Left and Right Eyes)
Resultant
Comparison
Test PairsTotal
Excluded
because Incomplete
(% of Total) Total
Excluded (% of Total)
Unreliable
Eye Lid
Artefact
Lens Rim
Artefact
SVOP v1 Glaucoma 67 128 23 (18) 134 8 (6) 0 (0) 0 (0) 98
Healthy 32 64 16 (25) 64 7 (11) 4 (6) 3 (5) 38
Total 99 192 39 (20) 198 15 (8) 4 (2) 3 (2) 136
SVOP v2 Glaucoma 36 70 5 (7) 72 4 (6) 1 (1) 0 (0) 60
Healthy 27 54 0 (0) 54 4 (7) 4 (7) 2 (4) 44
Total 63 124 5 (4) 126 8 (6) 5 (4) 2 (2) 109
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(excluding repeat tests), and the number of tests that
were excluded from analysis (incomplete SVOP tests
and SAP tests deemed unreliable due to false-
positive rates greater than 15%, or with artefact).
Finally, Table 1 also shows the resultant number of
comparison pairs (equivalent SVOP and SAP test
results) used for analysis after excluded tests are
removed.
Tables 2 and 3 show the number of subjects who
performed repeat testing for SVOP (v1 and v2) and
SAP, respectively. They also show the number of tests
excluded from analysis and the resultant repeat pairs
used for analysis.
Comparison of Thresholds Obtained with
SVOP and SAP
Overall there was good agreement between thresh-
old sensitivity values obtained with SVOP and SAP.
For example, Figure 2 shows the test outputs (SAP
and SVOP) for the left eye of a glaucoma patient.
Figure 3 shows the mean threshold values for SVOP
and SAP for SVOP v1 and v2 (r¼0.83 for v1 and 0.95
for v2).
Figure 4 shows the average thresholds for patients
and healthy subjects separately for SAP and SVOP
v2. Healthy subjects had a tight distribution of points
with sensitivity ranging approximately 28 to 31 dB for
SAP and 26 to 30 dB for SVOP.
Analysis also was performed on individual visual
field locations. This is of interest as the expected
thresholds across the visual field are expected to differ
dependent on the position tested. For example, Figure
5 shows threshold values for one visual field test
location (38 temporal, 98 superior) for SVOP v1 and
v2 and includes glaucoma patients and healthy
subjects.
Similar comparisons at each of the 54 visual field
point locations were performed. Figure 6 shows the
Pearson correlations (r) between tests at each
location. There was closer agreement between SAP
and SVOP v2 than between SAP and SVOP v1.
Repeatability of Threshold SVOP and SAP
To assess the repeatability of the numerical scores,
Pearson correlations were calculated for each pair of
repeat measurements on the same eye. For SVOP v1,
the average correlation over the 54 points was 0.66,
with a range of 0.37 to 0.85, indicating only moderate
repeatability. The lowest correlation of 0.37 was an
outlier, corresponding to the blind spot. For SVOP v2
Table 2. Number of Subjects Who Performed Repeat Testing for SVOP
SVOP Version Used
during Visit Subject Type N
Number of SVOP Tests
Resultant SVOP
Repeat PairsTotal
Excluded because
Incomplete (% of total)
SVOP v1 Glaucoma 38 76 3 (4) 35
Healthy 30 60 0 (0) 30
Total 68 136 3 (2) 65
SVOP v2 Glaucoma 11 22 0 (0) 11
Healthy 10 20 0 (0) 10
Total 21 42 0 (0) 21
Also shown is the number of tests, number of incomplete tests excluded from repeatability analysis, and the resultant
SVOP repeat pairs.
Table 3. Number of Subjects Who Performed Repeat Testing for SAP
Subject Type N
Number of SAP Tests
Resultant SAP
Repeat PairsTotal
Excluded (% of Total)
Unreliable Eye Lid Artefact Lens Rim Artefact
Glaucoma 49 98 8 (8) 0 (0) 0 (0) 42
Healthy 40 80 8 (10) 5 (6) 8 (10) 24
Total 89 178 16 (9) 5 (3) 8 (4) 66
Also shown is the number of tests, number of tests excluded from repeatability analysis, and the resultant SAP repeat
pairs.
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and SAP, the corresponding figures were 0.88 (0.66–
0.98) and 0.87 (0.69–0.96). Thus, the repeatability of
SVOP v2 was much better than that for v1, and
comparable to SAP. The individual test location
repeatability Pearson correlations, for SVOP v2 and
SAP, are shown in Figure 7.
Test Times
The mean test duration for patients performing the
SITA Fast test (number of tests [N]¼245, mean [M]¼
269.4, standard deviation [SD] ¼ 88.2) was signifi-
cantly shorter than SVOP v1 (mean difference of 2
minutes 31 seconds, N¼ 151, M¼ 420.5, SD¼ 161.3;
P , 0.001), and also was significantly shorter than
SVOP v2 (mean difference of 4 minutes 9 seconds, N
¼ 76, M ¼ 518.3, SD ¼ 155.2; P , 0.001).
Additionally, the test duration for patients perform-
ing SVOP v2 was significantly longer than SVOP v1
(mean difference of 1 min 38 seconds; P , 0.001).
The mean test duration for healthy subjects
performing SAP (N ¼ 143, M ¼ 189.1, SD ¼ 34.0)
was significantly shorter than SVOP v1 (mean
difference of 4 minutes 9 seconds, N ¼ 91, M ¼
437.6, SD ¼ 157.9; P , 0.001) and SAP was
significantly shorter than SVOP v2 (mean difference
of 5 minutes 31 seconds, N ¼ 64, M ¼ 520.3, SD ¼
148.5; P , 0.001). Additionally, test duration for
healthy subjects performing SVOP v2 was significant-
ly longer than SVOP v1 (mean difference of 1 minute
23 seconds; P ¼ 0.003).
Finally, the mean SAP test duration for patients
(N¼ 262, M¼ 268.2, SD¼ 86.8) compared to healthy
subjects (N ¼ 157, M ¼ 192.5, SD ¼ 37.7) was
significantly longer (P , 0.001).
Figure 2. Example test outputs for the left eye of a glaucoma patient. Upper: HFA device. Lower: Threshold SVOP.
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Discussion
This study revealed good correlation between
sensitivity values obtained using SAP and those
obtained using a new eye-tracking perimeter. There
was excellent agreement between average visual field
sensitivity using SVOP v2 and SAP, demonstrating
that SVOP can determine threshold visual field values
accurately when compared to the accepted gold
standard in patients with glaucoma. The study also
showed SVOP to have good repeatability, similar to
SAP for SVOP v2. Together these results suggested
that threshold SVOP could have use for evaluating
glaucomatous visual field loss, particularly in patients
who may struggle with conventional white-on-white
automated perimetry.
Overall average SVOP v2 and SAP thresholds
showed close agreement. A pointwise comparison of
SAP and SVOP thresholds revealed agreement
between SAP and SVOP varied depending on
location, with r values, excluding the blind spot,
ranging from 0.23 to 0.64 for SVOP v1, improving to
0.46 to 0.82 for SVOP v2. Correlation was lowest in
the superior and central test locations. Poorer
correlation in the central locations is likely to be
due to the difficulties of the eye tracker discriminating
the small changes in fixation needed to evaluate the
central visual field from eye gaze errors. The eye gaze
error reported by the eye tracker manufacturer is
,0.58. However, this can be greater in more
uncontrolled conditions, such as during an SVOP
test where a patient’s head may move or they may be
Figure 3. Mean thresholds (dB) for each visual field test. SVOP (v1
and v2) plotted against SAP. For SVOP v1, n ¼ 136, r ¼ 0.83. For
SVOP v2, n ¼ 109, r ¼ 0.95.
Figure 4. Mean thresholds (dB) for SVOP (v2) plotted against SAP
showing patients and healthy subjects (n¼ 109).
Figure 5. Mean thresholds (dB) for one visual field test location
(38 temporal, 98 superior) for SVOP v1 and v2 plotted against SAP.
n¼ 136 for SVOP v1, n¼ 109 for SVOP v2 (glaucoma patients and
healthy controls).
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wearing corrective lenses. The result is that some
stimuli that were perceived by the subject may not
have been recorded as ‘‘seen’’ by SVOP; consequently,
this resulted in lower threshold (dB) values being
produced by SVOP than SAP in the central 4 test
points, which is a finding reported previously by
another group who have developed eye gaze perim-
etry.15
The lower correlation for test points in the superior
visual field was attributed to these points sometimes
being tested towards the end of the test, meaning that
their presentation became more predictable due to
repetitive testing in these locations. The reason for
these test locations being left until the end stages of a
test primarily is because less screen area is available
for fixation that allow these points to be tested and,
hence, they are less likely to be selected during earlier
stages of the test. With knowledge of these limitations
and understanding of the data generated by the eye
tracker these issues can be resolved, for example by
changing the fixation requirements depending on the
test stimulus eccentricity of a point to be tested, and
by increasing the priority of testing certain locations
before the end of the test.
Overall SVOP v2 showed good repeatability with a
Pearson correlation of 0.88. The repeatability of
SVOP v2 on a point-by-point basis ranged from
0.66 to 0.98 (Fig. 7), with 45 of 54 points (83.3%)
having Pearson correlations of greater than 0.80. In
comparison, repeatability of SAP was 0.87, ranging
from 0.69 to 0.96, with 47 of 54 (87.0%) SAP test
points with correlations greater than 0.80. The points
with poorest repeatability for both tests were those in
the temporal field close to the blind spot. This also
was the case for SVOP v1, which showed an even
greater variability in the blind spot area.
SVOP v2 showed better agreement with SAP and
better repeatability compared to SVOP v1. It was felt
Figure 6. r values for SVOP v1 (left) and v2 (right) compared with SAP, for each individual test point location. n¼136 for SVOP v1, n¼109
for SVOP v2.
Figure 7. Pearson correlations for repeatability of SVOP v2 (left) and SAP (right), at each visual field test location. n¼ 21 for SVOP v2, n¼
66 for SAP.
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that improving the participant starting position
provided the greatest benefit, but also the small
changes and bug fixes ultimately contributed to the
overall improvements.
The SVOP threshold test currently has limitations.
First, it does not produce stimuli brighter than
equivalent to 14 dB on SAP. With a different display
screen, this could be improved to 10 dB, but it would
not be possible to achieve the brightness equivalent to
0 dB on SAP. Although the inability to generate
stimuli with intensity greater than 14 dB is a
limitation of SVOP, a recent study by Gardiner et
al.16 has suggested that due to a reduction in the
asymptotic maximum response probability, SAP may
be unreliable in test locations with sensitivity below 15
to 19 dB. This would make detection of progression in
areas of the visual field with sensitivity below this
level problematic and illustrates the need for alterna-
tive testing strategies to detect progression in areas of
the visual field with advanced loss. The display screen
also requires calibration to produce and maintain
accurate luminance presentation. The display calibra-
tion processes (factory and in-the-field maintenance
calibrations) could be automated easily.
A further limitation of threshold SVOP is that
some tests were not completed (11% and 5% of initial
SVOP tests attempted were incomplete for v1 and v2,
respectively). Incomplete tests largely were due to
poor quality eye tracking data, meaning that the test
could not proceed as it was unable to determine
accurately whether the subject was fixating correctly.
We observed a larger proportion of tests on glaucoma
patients being incomplete compared to healthy
subjects (15% and 3%, respectively, for SVOP v1,
7% and 0%, respectively, for v2). This is likely because
the eye tracker was developed for a normal popula-
tion and occurrences of ocular abnormalities (which
could interfere with the eye tracking) are more likely
to occur in the patient population. The Tobii eye
tracker uses video identification of corneal and pupil
reflexes. Incomplete tests due to poor eye tracking can
occur when the quality of the image of the pupil
margin and corneal reflex is impaired (e.g., due to
factors, such as dry eye, high diopter lenses, irregular
pupil shape, and eye makeup). The rate of incomplete
tests would need to be reduced to make the system
more acceptable for use in clinics. However, newer
models of eye trackers have introduced proprietary
developments to improve eye tracking and we have
begun work on a further iteration of the technique
using newer eye tracking hardware with promising
results when retesting some patients who produced
incomplete tests in this study.17 To further improve
SVOP, collaboration with eye tracking manufacturers
would be required to better understand the issues and
produce an eye tracker designed with the require-
ments of SVOP in mind. In addition, there also is
useful information on eye tracking quality, which can
be measured before the test (during the eye tracking
calibration) and during the test, which could be used
to ascertain how likely it is the test will complete.
It also is important to acknowledge that SVOP test
duration was significantly longer than SAP, for both
subject groups and for both SVOP software versions.
This primarily is due to the way in which the system
determines the threshold at each visual field test
location. The SITA fast algorithm, which was used
for SAP testing, uses a model to estimate threshold
values for each point based on responses to stimuli
presented at that location, as well as information
gathered from nearby locations, and tests consider-
ably fewer points than the SVOP test, which uses the
4-2 bracketing technique. Several techniques can be
incorporated into SVOP to improve test time. One
simple example would be to reduce the amount of
time SVOP waits to make an ‘‘unseen’’ decision.
Currently, this is set to 1 second, but a dynamic value
based on patient response time for ‘‘seen’’ stimuli
could be used. Given that near to 50% of stimuli in a
threshold test can be unseen, this would represent
considerable improvement in test time. SVOP v2 was
on average longer to complete than v1. The reason for
this primarily was because the number of stimulus
presentations was greater with v2 due to the
Figure 8. Mean test times for SAP and SVOP tests, for healthy
subjects and patients. Error bars: 2 standard errors of the mean.
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modification, which ensured that starting luminance
levels (calculated from neighboring completed test
locations) were never below 18 dB and because of the
longer period used to determine fixation. There was
no significant difference in the test times between
patients and healthy subjects performing SVOP in
contrast to SAP, where on average patients had a
longer test duration. This simply may be due to the
difference in algorithms used to determine threshold.
However, there are aspects of SAP testing that SVOP
bypasses (e.g., motor response time), which could
contribute to this effect and this warrants further
investigation.
Our study design also was limited by the need to
compare SVOP to SAP. Although SAP is the gold
standard, and the obvious choice for device valida-
tion, SAP itself is subject to variability. Difficulties
also were encountered with 5% of initial SAP tests,
where the data were deemed unreliable due to false-
positive responses exceeding 15% and subsequently
excluded from analysis. In all 30 of the ‘‘unreliable’’
SAP tests the corresponding SVOP test was complet-
ed successfully. Given the overall results demonstrat-
ing the accuracy of threshold SVOP, this indicates
that in these subjects SVOP would have provided a
useful result where SAP did not, indicating that
threshold SVOP, even in its current form, may prove
useful in a group of patients who struggle to perform
SAP reliably. False-positive responses on SAP occur
if the subject responds by pressing the button when no
stimulus is present. It is an indicator that the subject
may be ‘‘trigger happy’’ and affects the validity of the
visual field results. SVOP requires an eye gaze
response in the direction of the test stimulus and,
therefore, it is very difficult to make a conscious false-
positive response.
Threshold SVOP is an extension of our previously
described suprathreshold SVOP,11 which itself was an
extension of work performed by Bertil Damato in
1985.18 As would be expected the testing times for
threshold SVOP are longer compared to suprathresh-
old SVOP (143 seconds longer in adults and 82
seconds longer in healthy adults). Both forms of
SVOP testing perform well in healthy subjects and
glaucoma patients (suprathreshold SVOP showed a
sensitivity and specificity of 69.3% and 96.6% in
adults when analyzing individual test points).
In this study, we demonstrated an alternative
method of measuring threshold visual fields that is
repeatable and compares well with the current gold
standard. Although further work is required to
achieve a faster test and improve test accuracy in
the central locations, we demonstrated how iterative
improvements can be made through software. More
data are required to create a larger database of
normative SVOP thresholds and assess more subtle
differences between SVOP and SAP (for example
correlation at different retinal sensitivities or stages of
glaucoma). Further developments and improvements
to the SVOP system are possible through advances in
eye tracking technology and newer models of eye
tracker currently are available that may improve eye
tracking in patients who have proved difficult to test
thus far. The second part to this study demonstrates
how a further iteration of the threshold SVOP system
can improve on the rates of incomplete testing, which,
coupled with positive patient feedback, make the test
a useful and acceptable form of perimetry.17 Addi-
tional future work will be necessary to assess other
outputs available from threshold SVOP tests, such as
saccadic reaction times, which may provide additional
diagnostic information,19 and correlation of threshold
SVOP with retinal nerve fiber layer density.
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